@article{558428eed40f42d49f099b0148d39bde,
title = "Targeting Inflammation in the Prevention and Treatment of Type 2 Diabetes: Insights From CANTOS∗",
keywords = "atherosclerosis, diabetes, inflammation",
author = "Subodh Verma and Verghese Mathew and Farkouh, {Michael E.}",
note = "Funding Information: Dr. Verma has received research grants and/or speaking honoraria from Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, Eli Lilly, Janssen, Merck, Novartis, Novo Nordisk, Sanofi, and Valeant. Dr. Farkouh has received research grants from Amgen and Novo Nordisk. Dr. Mathew has reported that he has no relationships relevant to the contents of this paper to disclose. ",
year = "2018",
month = may,
day = "29",
doi = "10.1016/j.jacc.2018.03.480",
language = "English (US)",
volume = "71",
pages = "2402--2404",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "21",
}